Grooming with a stone in sooty mangabeys (Cercocebus atys).

Am J Primatol

Department of Psychology, University of Georgia, Athens, and Yerkes Regional Primate Research Center of Emory University, Field Station, Lawrenceville, Georgia.

Published: January 1988

"Stone-grooming," or grooming with a stone, has been reported in Macaca fuscata. This report provides a descriptive account of a similar behavior displayed by a female mangabey Cercocebus atys. During a study of embracing behavior in sooty mangabeys, one adult female was observed to groom her infant with a stone. The grooming pattern involved short strokes and/or a circular motion over the area being groomed-the infant's eye region. Stone-grooming appears to be a distinct type of grooming although the function(s) of this behavior remains unclear. The use of a stone in grooming may represent a case of tool use.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajp.1350160208DOI Listing

Publication Analysis

Top Keywords

grooming stone
8
sooty mangabeys
8
cercocebus atys
8
stone grooming
8
grooming
5
stone sooty
4
mangabeys cercocebus
4
atys "stone-grooming"
4
"stone-grooming" grooming
4
stone reported
4

Similar Publications

Introduction: Although SARS-CoV-2 vaccines were first approved under Emergency Use Authorization by the Food and Drug Administration in late 2020 for adults, authorisation for young children 6 months to <5 years of age did not occur until 2022. These authorisations were based on clinical trials, understanding real-world vaccine effectiveness (VE) in the setting of emerging variants is critical. The primary goal of this study is to evaluate SARS-CoV-2 VE against infection among children aged >6 months and adults aged <50 years.

View Article and Find Full Text PDF

Honey Bee (Apis mellifera) Immunity.

Vet Clin North Am Food Anim Pract

November 2021

Professor and Head of the Honey Bee Research Centre, University of Guelph, School of Environmental Sciences, 50 Stone Road East, N1G 2W1, Guelph, Ontario, Canada.

At the individual level, honey bees (Apis mellifera) rely on innate immunity, which operates through cellular and humoral mechanisms, to defend themselves against infectious agents and parasites. At the colony level, honey bees have developed collective defense mechanisms against pathogens and pests, such as hygienic and grooming behaviors. An understanding of the immune responses of honey bees is critical to implement strategies to reduce mortality and increase colony productivity.

View Article and Find Full Text PDF

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.

N Engl J Med

November 2021

From Baylor College of Medicine, Houston (H.M.E.S.), and Javara, The Woodlands (C.K.) - both in Texas; Brigham and Women's Hospital, Boston (L.R.B.), and Moderna, Cambridge (A.A., H.C., W.D., S.H., B.L., D.M., R.P., F.S., J.E.T., H.Z., J.M.) - both in Massachusetts; Meridian Clinical Research, Baton Rouge, LA (B.E., F.E.); University of Miami, Miami (S.D.-L.), and DeLand Clinical Research Unit, DeLand (B.R.) - both in Florida; University of Pittsburgh School of Medicine, Pittsburgh (J.M.M.); Emory University School of Medicine, Atlanta (E.J.A.); University of Colorado School of Medicine, Aurora (T.B.C.); University of California, Los Angeles (J.C.), and Wake Research-Medical Center for Clinical Research, San Diego (L.H.-C.) - both in California; Kaiser Permanente Washington Health Research Institute (L.A.J.), and Fred Hutchinson Cancer Research Center (L.C., P.G., H.J.) - both in Seattle; University of Cincinnati, Cincinnati (C.J.F.); Henry Ford Health System, Detroit (M.Z.); Vitalink Research, Greenville, SC (G.F.); Clinical Research Center of Nevada, Wake Research, Las Vegas (M.L.); and the University of Maryland, College Park (K.M.N.), and the Vaccine Research Center (J.R.M., J.E.L., B.S.G.), National Institute of Allergy and Infectious Diseases (D.F., M.M., L.P.), National Institutes of Health, Bethesda - both in Maryland.

Background: At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 (Covid-19). After emergency use of the vaccine was authorized, the protocol was amended to include an open-label phase.

View Article and Find Full Text PDF

Infant handling increases grooming towards mothers in wild geladas (Theropithecus gelada).

Behav Processes

November 2021

Department of Life Sciences and Systems Biology, University of Torino, Via Accademia Albertina 13, 10123 Torino, Italy; Natural History Museum, University of Pisa, Via Roma 79, Pisa, 56011 Calci, Italy. Electronic address:

Infant handling - involving affiliative behavior from non-mothers to infants - is a phenomenon that is variably present in Old World monkeys and can be granted by mothers to obtain social services, such as grooming. Here we investigated for the first time whether infant handling could influence grooming exchange in wild geladas. We gathered data on the population of Kundi highland (Ethiopia) in 2019/2020.

View Article and Find Full Text PDF

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

N Engl J Med

February 2021

From Brigham and Women's Hospital (L.R.B.), Boston, and Moderna, Cambridge (H.B., R.P., C.K., B.L., W.D., H.Z., S.H., M.I., J. Miller, T.Z.) - both in Massachusetts; Baylor College of Medicine (H.M.E.S.) and Centex Studies (J.S.) - both in Houston; Meridian Clinical Research, Savannah (B.E., S.K., A.B.), and Emory University (N.R.) and Atlanta Clinical Research Center (N.S.), Atlanta - all in Georgia; University of Maryland School of Medicine, Baltimore (K.K., K.N.), and National Institute of Allergy and Infectious Diseases, Bethesda (D.F., M.M., J. Mascola, L.P., J.L., B.S.G.) - both in Maryland; Saint Louis University School of Medicine, St. Louis (S.F.); University of Illinois, Chicago, Chicago (R.N.); George Washington University School of Medicine and Health Sciences, Washington, DC (D.D.); University of California, San Diego, San Diego (S.A.S.); Vanderbilt University School of Medicine, Nashville (C.B.C.); Quality of Life Medical and Research Center, Tucson, AZ (J. McGettigan); Johnson County Clin-Trials, Lenexa, KS (C.F.); Research Centers of America, Hollywood, FL (H.S.); and Fred Hutchinson Cancer Research Center, Seattle (L.C., P.G., H.J.).

Background: Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19.

Methods: This phase 3 randomized, observer-blinded, placebo-controlled trial was conducted at 99 centers across the United States.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!